Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Lipidology|September 11, 2018
Key aspects of PCSK9 inhibition beyond LDL loweringStéphane Ramin-Mangata, Valentin Blanchard, Gilles Lambert
Biochemical and Biophysical Research Communications|December 27, 2025
Bacteriocins in plant pathology: current knowledge, application, challenges and perspectivesEva Caly-Simbou, Stéphane Ramin-Mangata, Stéphane Poussier, et al.
Pathology|December 8, 2018
PCSK9: from biology to clinical applicationsValentin Blanchard, Ilya Khantalin, Stéphane Ramin-Mangata, et al.
Immunology|July 24, 2019
CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNABrice Nativel, Stéphane Ramin-Mangata, Rudy Mevizou, et al.
Nutrients|January 22, 2021
Protective Effects of Medicinal Plant Decoctions on Macrophages in the Context of AtherosclerosisEloïse Checkouri, Stéphane Ramin-Mangata, Nicolas Diotel, et al.
Atherosclerosis|December 14, 2019
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetesStéphane Ramin-Mangata, Matthieu Wargny, Matthieu Pichelin, et al.
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Pageof 2